Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo

Journal of Neurophysiology

Volumn 83, Issue 4, 2000, Pages 1796-1808

  West, Anthony R ^a,b   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ELECTROSTIMULATION; INTERNEURON; MALE; MESENCEPHALON; MICRODIALYSIS; NERVE CELL STIMULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 0034111873     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2000.83.4.1796     Document Type: Article

References (75)

1. ARIANO, M. A. Distribution of the components of the guanosine 3′,5′-phosphate system in rat caudate-putamen. Neuroscience 10: 707-723, 1983.
2. BOLAM, P. AND SMITH, D. The GABA and substance P input to dopaminergic neurons in the substantia nigra of the rat. Brain Res. 529: 57-78, 1990.
3. BRASZKO, J. J., BANNON, M. J., BUNNEY, B. S., AND ROTH, R. H. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. J. Pharmacol. Exp. Ther. 216: 289-293, 1981.
4. BREDT, D. S., GLATT, C. E., HWANG, P. M., FOTUHI, M., DAWSON, T., AND SNYDER, S. H. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH-diaphorase. Neuron 7: 615-624, 1991.
5. BREDT, D. S., HWANG, P. M., AND SYNDER, S. H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768-770, 1990.
6. BUNNEY, B. S. AND GRACE, A. A. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Lift Sci. 23: 1715-1728, 1978.
7. CALABRESI, P., GUBELLINI, P., CENTONZE, D., SANCESARIO, G., MORELLO, M., GIORGI, M., PISANI, A., AND BERNARDI, G. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19: 2489-2499, 1999.
8. CARLSSON, M. AND CARLSSON, A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13: 272-276, 1990.
9. CHIODO, L. A. AND BUNNEY, B. S. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3: 1607-1619, 1983.
10. COLLINGRIDGE, G. L. AND DAVIES, J. The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra. Brain Res: 212: 345-359, 1981.
11. DAI, M. AND TEPPER, J. M. Do silent dopaminergic neurons exist in rat substantia nigra in vivo? Neuroscience 85: 1089-1099, 1998.
12. DENIAU, J. M., MENETREY, A., AND CHARPIER, S. The lamellar organization of the rat substantia nigra pars reticulata: segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience 73: 761-781, 1996.
13. DRAY, A., GONYE, T. J., AND OAKLEY, N. R. Caudate stimulation and substantia nigra activity in the rat. J. Physiol. (Lond.) 259: 825-849, 1976.
14. FIGUEREDO-CARDENAS, G., MORELLO, M., SANCESARIO, G., BERNARDI, G., AND REINER, A. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res. 735: 317-324, 1996.
15. FUJIYAMA, F. AND MASUKO, S. Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry. Brain Res. Bull. 40: 121-127, 1996.
16. GARIANO, R. F. AND GROVES, P. M. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res. 462: 194-198, 1988.
17. GARTHWAITE, J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14: 60-67, 1991.
18. GARTHWAITE, J. AND BOULTON, C. L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57: 683-706, 1995.
19. GARTHWAITE, J., CHARLES, S. L., AND CHESS-WILLIAMS, R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388, 1988.
20. GOSWELL, M. J. AND SEDGWICK, E. M. Is there a cortico-nigral tract? Some neurophysiological observations. Brain Res. 50: 437-440, 1973.
21. GRACE, A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1-24, 1991.
22. GRACE, A. A. AND BUNNEY, B. S. Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol. 59: 211-218, 1979.
23. GRACE, A. A. AND BUNNEY, B. S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons. I. Identification and characterization. Neuroscience 10: 301-315, 1983.
24. GRACE, A. A. AND BUNNEY, B. S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4: 2877-2890, 1984.
25. GRACE, A. A. AND BUNNEY, B. S. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res. 333: 271-284, 1985.
26. GROFOVA, I. The identification of striatal and pallidal neurons projecting to substantia nigra. An experimental study by means of retrograde axonal transport of horseradish peroxidase. Brain Res. 91: 286-291, 1975.
27. GUEVARA-GUZMAN, R., EMSON, P. C., AND KENDRICK, K. M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic-GMP. J. Neurochem. 62: 807-810, 1994.
28. HABER, S. N. AND FUDGE, J. L. The primate substantia nigra and VTA: integrative circuitry and function. Crit. Rev. Neurobiol. 11: 323-342, 1997.
29. HARDEN, D. G. AND GRACE, A. A. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment. J. Neurosci. 15: 6157-6166, 1995.
30. JONES, E. G., COULTER, J. D., BURTON, H., AND PORTER, R. Cells of origin and termination of corticostriatal fibers arising in the sensory-motor cortex of monkeys. J. Comp. Neurol. 173: 53-80, 1977.
31. JONES, N. M., LOIACONO, R. E., MOLLER, M., AND BEART, P. M. Diverse roles for nitric oxide in synaptic signalling after activation of NMDA release-regulating receptors. Neuropharmacology 33: 1351-1356, 1994.
32. KENDRICK, K., GUEVARA-GUZMAN, R., RIVA, C., CHRISTENSEN, J., OSTERGAARD, K., AND EMSON, P. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur. J. Neurosci. 8: 2619-2634, 1996.
33. KERKARIAN, L., BOSLER, O., PELLETIER, G., AND NIEOULLON, A. Striatal neuropeptide Y neurons are under the influence of nigrostriatal dopaminergic pathway: immunohistochemical evidence. Neurosci. Lett. 66: 106-112, 1986.
34. KHARAZIA, V. N., SCHMIDT, H.H.H.W., AND WEINBERG, R. J. Type 1 nitric oxide synthase fully accounts for NADPH-diaphorase in rat striatum but not cortex. Neuroscience 62: 983-987, 1994.
35. KORNHUBER, J., KIMM, J.-S., KORNHUBER, M. E., AND KORNHUBER, H. H. The cortico-nigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res. 322: 124-126, 1984.
36. KUBOTA, Y., INAGAKI, S., KITO, S., SHIMADA, S., OKAYAMA, T., HATANAKA, H., PELLETIER, G., TAKAGI, H., AND TOHYAMA, M. Neuropeptide Y-immunoreactive neurons receive synaptic inputs from dopaminergic axon terminals in the rat striatum. Brain Res. 458: 389-393, 1988.
37. MARIN, P., LAFON-CAZAL, M., AND BOCKAERT, J. A nitric oxide activity selectively stimulated by NMDA receptors depends on protein kinase C activation in mouse striatal neurons. Eur. J. Neurosci. 4: 425-432, 1992.
38. MARIN, P., QUIGNARD, J. F., LAFON-CAZAL, M., AND BOCKAERT, J. Non-classical glutamatergic receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons. Neuropharmacology 32: 29-36, 1993.
39. MOORE, H., TODD, C. L, AND GRACE, A. A. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons. J. Neurosci. 18: 5068-5077, 1998.
40. MOORE, H., WEST, A. R., AND GRACE, A. A. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol. Psychiatry 46: 40-55, 1999.
41. NAITO, A. AND KITA, H. The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine. Brain Res. 637: 317-322, 1994.
42. NAKAHARA, K., YOKOO, H., YOSHIDA, M., TANAKA, M., AND SHIGEMORI, M. Effect of nitric oxide on central dopamine neurons. Brain Nerve 46: 1147-1153, 1994.
43. NAKAMURA, S., IWATSUBO, K., TSAI, C. T., AND IWAMA, K. Cortically induced inhibition of neurons of rat substantia nigra (pars compacta). Jpn. J. Physiol. 29: 353-357, 1979a.
44. NAKAMURA, S., IWATSUBO, K., TSAI, C. T., AND IWAMA, K. Neuronal activity of the substantia nigra (pars compacta) after injection of kainic acid into the caudate nucleus. Exp. Neurol. 66: 682-691, 1979b.
45. O'DONNELL, P. AND GRACE, A. A. Cortical afferents modulate striatal gap junction permeability via nitric oxide. Neuroscience 76: 1-5, 1997.
46. O'DONNELL, P. AND GRACE, A. A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr. Bull. 24: 267-283, 1998.
47. OVERTON, P. G., TONG, Z. Y., AND CLARK, D. A pharmacological analysis of the burst events induced in midbrain dopaminergic neurons by electrical stimulation of the prefrontal cortex in the rat. J. Neural Transm. 103: 523-540, 1996.
48. PARK, J.-H., STRAUB, V. A., AND O'SHEA, M. Anterograde signaling by nitric oxide: characterization and in vitro reconstitution of an identified nitrergic synapse. J. Neurosci. 18: 5463-5476, 1998.
49. PAXINOS, G. AND WATSON, C. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1986.
50. PRECHT, W. AND YOSHIDA, M. Blockade of caudate-evoked inhibition of neurons in the substantia nigra by picrotoxin. Brain Res. 32: 229-233, 1971.
51. SALIN, P., KERKERIAN-LE GOFF, L., HEIDET, V., EPELBAUM, J., AND NIEOULLON, A. Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions. Brain Res. 521: 23-32, 1990.
52. SCHULTZ, W., TREMBLAY, L., AND HOLLERMAN, J. R. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37: 421-429, 1998.
53. SHIM, S. S., BUNNEY, B. S., AND SHI, W. X. Effects of lesions of the medial prefrontal cortex on the activity of midbrain dopamine neurons. Neuropsychopharmacology 15: 437-441, 1996.
54. SMITH, D. AND BOLAM, P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13: 259-265, 1990.
55. SOMOGYI, P., BOLAM, J. P., AND SMITH, A. D. Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure. J. Comp. Neurol. 195: 567-584, 1981.
56. SOUTHAM, E., AND GARTHWAITE, J. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci. Lett. 130: 107-111, 1991.
57. SPATZ, M., YASUMA, Y., STRASSER, A., KAWAI, N., STANIMIROVIC, D., AND MCCARRON, R. M. Modulation of striatal dopamine release in cerebral ischemia by L-arginine. Neurochem. Res. 20: 491-496, 1995.
58. STRASSER, A., MCCARRON, R. M., ISHII, H., STANIMIROVIC, D., AND SPATZ, M. L-arginine induces dopamine release from the striatum in vivo. Neuroreport 5: 2298-2300, 1994.
59. TEPPER, J. M., TRENT, F., AND NAKAMURA, S. Postnatal development of the electrical activity of rat nigrostriatal dopaminergic neurons. Dev. Brain Res. 54: 21-33, 1990.
60. TONG, Z. Y., OVERTON, P. G., AND CLARK, D. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat. Brain Res. 674: 63-74, 1995.
61. TONG, Z. Y., OVERTON, P. G., AND CLARK, D. Stimulation of the prefrontal cortex in rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse 22: 195-208, 1996.
62. TSOU, K., SNYDER, G., AND GREENGARD, P. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine and cAMP-regulated phosphoprotein in the substantia nigra. Proc. Natl. Acad. Sci. USA 90: 3462-3465, 1993.
63. VINCENT, S. R. AND JOHANSSON, O. Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscope study. J. Comp. Neurol. 217: 264-270, 1983.
64. VUILLET, J., KERKERIAN, L., KACHIDIAN, P., BOSLER, O., AND NIEOULLON, A. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci. Lett. 100: 99-104, 1989a.
65. VUILLET, J., KERKERIAN, L., SALIN, P., AND NIEOULLON, A. Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Res. 477: 241-251, 1989b.
66. WALAAS, S. I., GIRAULT, J. A., AND GREENGARD, P. Localization of cyclic GMP-dependent protein kinase in rat basal ganglia neurons. J. Mol. Neurosci. 1: 243-250, 1989.
67. w-Hydroxy-L-arginine: a novel arginine analog capable of causing vasorelaxation in bovine intrapulmonary artery. Biochem. Biophys. Res. Commun. 176: 528-534, 1991.
68. WASSEF, M., BEROD, A., AND SOTELO, C. Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration. Neuroscience 6: 2125-2139, 1981.
69. WEST, A. R. AND GALLOWAY, M. P. Intrastriatal infusion of (±)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. J. Neurochem. 66: 1971-1980, 1996.
70. WEST, A. R. AND GALLOWAY, M. P. Inhibition of glutamate reuptake potentiates endogenous nitric oxide facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study. Neurosci. Lett. 230: 21-24, 1997a.
71. WEST, A. R. AND GALLOWAY, M. P. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 36: 1571-1581, 1997b.
72. WEST, A. R. AND GALLOWAY M. P. Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms. Neurochem. Int. 33: 493-501, 1998.
73. WEST, A. R. AND GRACE, A. A. Intrastriatal infusion of nitric oxide increases the firing rate and duration of burst firing of striatal neurons recorded in vivo. Soc. Neurosci. Abstr. 25: 173, 1999.
74. WHITE, F. J. AND WANG, R. Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221: 1054-1057, 1983.
75. YOSHIDA, M. AND PRECHT, W. Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers. Brain Res. 32: 225-228, 1971.